These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 22935464

  • 1. Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy.
    Todiere G, Aquaro GD, Piaggi P, Formisano F, Barison A, Masci PG, Strata E, Bacigalupo L, Marzilli M, Pingitore A, Lombardi M.
    J Am Coll Cardiol; 2012 Sep 04; 60(10):922-9. PubMed ID: 22935464
    [Abstract] [Full Text] [Related]

  • 2. Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy.
    Choi HM, Kim KH, Lee JM, Yoon YE, Lee SP, Park EA, Lee W, Kim YJ, Cho GY, Sohn DW, Kim HK.
    Heart; 2015 Jun 04; 101(11):870-6. PubMed ID: 25897040
    [Abstract] [Full Text] [Related]

  • 3. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
    Rudolph A, Abdel-Aty H, Bohl S, Boyé P, Zagrosek A, Dietz R, Schulz-Menger J.
    J Am Coll Cardiol; 2009 Jan 20; 53(3):284-91. PubMed ID: 19147047
    [Abstract] [Full Text] [Related]

  • 4. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Rubinshtein R, Glockner JF, Ommen SR, Araoz PA, Ackerman MJ, Sorajja P, Bos JM, Tajik AJ, Valeti US, Nishimura RA, Gersh BJ.
    Circ Heart Fail; 2010 Jan 20; 3(1):51-8. PubMed ID: 19850699
    [Abstract] [Full Text] [Related]

  • 5. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.
    Moravsky G, Ofek E, Rakowski H, Butany J, Williams L, Ralph-Edwards A, Wintersperger BJ, Crean A.
    JACC Cardiovasc Imaging; 2013 May 20; 6(5):587-96. PubMed ID: 23582356
    [Abstract] [Full Text] [Related]

  • 6. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA, Monserrat L, Soler R, Rodríguez E, Fernández X, Peteiro J, Bouzas B, Piñón P, Castro-Beiras A.
    Rev Esp Cardiol; 2007 Jan 20; 60(1):15-23. PubMed ID: 17288951
    [Abstract] [Full Text] [Related]

  • 7. Progression of Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Cardiac Magnetic Resonance Study.
    Habib M, Adler A, Fardfini K, Hoss S, Hanneman K, Rowin EJ, Maron MS, Maron BJ, Rakowski H, Chan RH.
    JACC Cardiovasc Imaging; 2021 May 20; 14(5):947-958. PubMed ID: 33248971
    [Abstract] [Full Text] [Related]

  • 8. Scoring of late gadolinium enhancement in cardiac magnetic resonance imaging can predict cardiac events in patients with hypertrophic cardiomyopathy.
    Nojiri A, Hongo K, Kawai M, Komukai K, Sakuma T, Taniguchi I, Yoshimura M.
    J Cardiol; 2011 Nov 20; 58(3):253-60. PubMed ID: 21890327
    [Abstract] [Full Text] [Related]

  • 9. Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy.
    Prinz C, Schwarz M, Ilic I, Laser KT, Lehmann R, Prinz EM, Bitter T, Vogt J, van Buuren F, Bogunovic N, Horstkotte D, Faber L.
    Can J Cardiol; 2013 Mar 20; 29(3):358-63. PubMed ID: 22749647
    [Abstract] [Full Text] [Related]

  • 10. Myocardial blood flow and fibrosis in hypertrophic cardiomyopathy.
    Aquaro GD, Todiere G, Barison A, Strata E, Marzilli M, Pingitore A, Lombardi M.
    J Card Fail; 2011 May 20; 17(5):384-91. PubMed ID: 21549295
    [Abstract] [Full Text] [Related]

  • 11. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.
    Moon JC, Mogensen J, Elliott PM, Smith GC, Elkington AG, Prasad SK, Pennell DJ, McKenna WJ.
    Heart; 2005 Aug 20; 91(8):1036-40. PubMed ID: 16020591
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.
    Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T, Lesser JR, Gruner C, Crean AM, Rakowski H, Udelson JE, Rowin E, Lombardi M, Cecchi F, Tomberli B, Spirito P, Formisano F, Biagini E, Rapezzi C, De Cecco CN, Autore C, Cook EF, Hong SN, Gibson CM, Manning WJ, Appelbaum E, Maron MS.
    Circulation; 2014 Aug 05; 130(6):484-95. PubMed ID: 25092278
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.
    O'Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R, Webb J, Kulkarni M, Dawson D, Sulaibeekh L, Chandrasekaran B, Bucciarelli-Ducci C, Pasquale F, Cowie MR, McKenna WJ, Sheppard MN, Elliott PM, Pennell DJ, Prasad SK.
    J Am Coll Cardiol; 2010 Sep 07; 56(11):867-74. PubMed ID: 20688032
    [Abstract] [Full Text] [Related]

  • 14. Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia.
    Petkow-Dimitrow P, Klimeczek P, Vliegenthart R, Pasowicz M, Miszalski-Jamka T, Oudkerk M, Podolec P, Dubiel JS, Tracz W.
    Kardiol Pol; 2009 Aug 07; 67(8A):964-9. PubMed ID: 19784900
    [Abstract] [Full Text] [Related]

  • 15. Myocardial fibrosis attenuates the effect of cibenzoline on left ventricular diastolic function in patients with hypertrophic cardiomyopathy.
    Saito M, Okayama H, Yoshii T, Hiasa G, Sumimoto T, Inaba S, Nishimura K, Inoue K, Ogimoto A, Shigematsu Y, Funada J, Hamada M, Higaki J.
    J Cardiovasc Pharmacol; 2011 Feb 07; 57(2):207-12. PubMed ID: 21052009
    [Abstract] [Full Text] [Related]

  • 16. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
    Bogarapu S, Puchalski MD, Everitt MD, Williams RV, Weng HY, Menon SC.
    Pediatr Cardiol; 2016 Apr 07; 37(4):663-73. PubMed ID: 26833321
    [Abstract] [Full Text] [Related]

  • 17. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP, Chakrabarty A, Shipp N, Molaee P, Madsen PL, Joerg L, Sullivan T, Worthley SG, De Pasquale CG, Sanders P, Selvanayagam JB.
    Eur Heart J; 2012 Mar 07; 33(5):640-8. PubMed ID: 22048681
    [Abstract] [Full Text] [Related]

  • 18. T-wave inversions related to left ventricular basal hypertrophy and myocardial fibrosis in non-apical hypertrophic cardiomyopathy: a cardiovascular magnetic resonance imaging study.
    Chen X, Zhao S, Zhao T, Lu M, Yin G, Jiang S, Prasad S.
    Eur J Radiol; 2014 Feb 07; 83(2):297-302. PubMed ID: 24332848
    [Abstract] [Full Text] [Related]

  • 19. Myocardial Fibrosis in Hypertrophic Cardiomyopathy: Volumetric Assessment of Late Enhancement Provided by Cardiac Computed Tomography.
    Langer C, Schaefer P, Lutz M, Eden M, Hohnhorst M, Harders H, Faber L, Jansen O, Both M, Frey N.
    J Comput Assist Tomogr; 2015 Feb 07; 39(5):797-803. PubMed ID: 26125299
    [Abstract] [Full Text] [Related]

  • 20. Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    Olivotto I, Maron BJ, Appelbaum E, Harrigan CJ, Salton C, Gibson CM, Udelson JE, O'Donnell C, Lesser JR, Manning WJ, Maron MS.
    Am J Cardiol; 2010 Jul 15; 106(2):261-7. PubMed ID: 20599013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.